N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2

FL Poe, J Corn - Medical hypotheses, 2020 - Elsevier
… to support the use of NAC as a potential therapeutic agent in the treatment of COVID-19. …
In this article, we present evidence to support the use of NAC as a treatment for COVID-19. …

[HTML][HTML] Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19

…, KC Manish, S Razzack, N Moallem… - World Journal of …, 2021 - ncbi.nlm.nih.gov
… knowledge of biochemistry, current uses of NAC in clinical … COVID-19, it is worthwhile
to investigate further whether this agent can be used as a treatment or adjuvant for COVID-19. …

Application of methylene blue-vitamin C–N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial

DH Alamdari, AB Moghaddam, S Amini… - European journal of …, 2020 - Elsevier
COVID-19 is a global catastrophic event that causes severe … The microbial threat as induced
by COVID-19 causes the … were measured in 25 ICU COVID-19 patients and 25 healthy …

N-acetylcysteine as a part of complex treatment of moderate COVID-associated pneumonia

V Gaynitdinova, S Avdeev, Z Merzhoeva… - 2021 - covid19.neicon.ru
N-acetylcysteine's (NAC) pharmacological activity and its … of COVID-19 make it a promising
therapeutic agent for COVID-… use of N-acetylcysteine as a candidate drug to treat COVID-…

Evaluation the efficacy and safety of Nacetylcysteine inhalation spray in controlling the symptoms of patients with COVID19: An open‐label randomized controlled …

Y Panahi, M Ghanei, M Rahimi, A Samim… - Journal of Medical …, 2023 - Wiley Online Library
… of N-acetylcysteine (NAC) inhalation spray in the treatment of patients with coronavirus disease
2019 (COVID-19)… The present study provides evidence that the use of 400 μg/day of NAC …

[PDF][PDF] N-acetylcysteine as a therapeutic approach to post-COVID-19 pulmonary fibrosis adjunctive treatment.

C Micheletto, JL Izquierdo, SN Avdeev… - European Review for …, 2022 - europeanreview.org
… It is provided with a high safety profile, as shown by years of use. This article describes
the mechanisms supporting the possible use of NAC as an adjuvant treatment for post-COVID-19

[HTML][HTML] N-acetylcysteine and coronavirus disease 2019: May it work as a beneficial preventive and adjuvant therapy? A comprehensive review study

N Atefi, E Behrangi, S Mozafarpoor… - Journal of Research …, 2020 - journals.lww.com
… In the present study, there is no RCT that has used NAC in COVID-19 patients. In the latest
search update of the article, three studies were found that their researchers agreed on the …

[HTML][HTML] Use of thiols in the treatment of COVID-19: current evidence

M Cazzola, P Rogliani, SS Salvi, J Ora, MG Matera - Lung, 2021 - Springer
… The importance of oxidative stress during COVID-19 and the various pharmacological … of
COVID-19. Oral and intravenous GSH, as well as GSH precursors such as N-acetylcysteine (…

Drug utilization of N-Acetylcysteine in COVID-19 inpatients at Santa Elisabeth Hospital, Purwokerto

H Ekowati, FQ Nadzif, MW Suryoputri - Acta Pharmaciae Indonesia …, 2022 - jos.unsoed.ac.id
… Objective: The purpose of this study is to evaluate at the NAC usage profile in COVID-19
therapy in COVID-19. As a result, the goal of this study is to determine the pattern of NAC use at …

NAcetylcysteine and Other Sulfur‐Donors as a Preventative and Adjunct Therapy for COVID19

HN du Preez, C Aldous, HG Kruger… - Advances in …, 2022 - Wiley Online Library
… Even though we propose that NAC and STS can be used as first-line therapy, their
application would complement any other treatment protocol as a safe adjunct intervention. …